Related Experiment Video

Updated: Jul 7, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Mathematical modeling of cytotoxic lymphocyte-mediated immune response to hepatitis B virus infection

Changjiang Long1, Huan Qi, Sheng-Hu Huang

  • 1School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China.

Journal of Biomedicine & Biotechnology
|March 5, 2008
PubMed

Insights

A new mathematical model simulates hepatitis B virus (HBV) infection and the immune response. The model indicates that a strong cytotoxic lymphocyte (CTL) response is crucial for clearing HBV and recovering from infection.

Area of Science:

  • Immunology
  • Mathematical Biology
  • Hepatology

Background:

  • Cytotoxic lymphocyte (CTL) responses are key in viral infections.
  • Existing models, like Nowak's for HIV, don't fully capture hepatitis B virus (HBV) dynamics.
  • CTL recruitment to the liver is a novel concept in HBV pathogenesis.

Purpose of the Study:

  • To develop a mathematical model for HBV infection.
  • To analyze the relationship between HBV, CTL response, and liver damage (ALT).
  • To explore conditions for complete HBV elimination.

Main Methods:

  • Developed a novel mathematical model.
  • Simulated HBV infection dynamics using various parameters.
  • Analyzed the stability of the complete recovery equilibrium point.

Main Results:

  • The model successfully interprets diverse clinical presentations of HBV infection.
  • Simulations show a correlation between CTL response strength and infection outcome.
  • Identified conditions related to the complete recovery equilibrium.

Conclusions:

  • A rapid and robust CTL response is essential for resolving HBV infection.
  • The developed model provides insights into HBV pathogenesis and immune interaction.
  • Mathematical modeling can elucidate complex viral-immune dynamics in liver diseases.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...